Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Patients With Cancer: A Systematic Review and Trade-Off Analysis From 9 Randomized Controlled Trials

Venous thromboembolism (VTE) is highly prevalent in patients with cancer. Non-vitamin K antagonist oral anticoagulants (NOACs), directly targeting the enzymatic activity of thrombin or factor Xa, have been shown to be as effective as and safer than traditional anticoagulation for VTE prophylaxis in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yi-Dan, Zhang, Chi, Shen, Long, Su, Ying-Jie, Liu, Xiao-Yan, Wang, Li-Wei, Gu, Zhi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005885/
https://www.ncbi.nlm.nih.gov/pubmed/29946255
http://dx.doi.org/10.3389/fphar.2018.00575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005885/
https://www.ncbi.nlm.nih.gov/pubmed/29946255
http://dx.doi.org/10.3389/fphar.2018.00575

Ejemplares similares